Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

2.56USD
4:00pm EDT
Change (% chg)

$0.14 (+5.79%)
Prev Close
$2.42
Open
$2.51
Day's High
$2.56
Day's Low
$2.41
Volume
5,825
Avg. Vol
2,763
52-wk High
$4.21
52-wk Low
$2.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.23 -0.109
FY 2017 Dec '17 0.87 -0.104
Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
FY 2016 Dec '16 0.99 -0.112
Sep '16 1.14 0.104
Jun '16 0.58 -0.173
Mar '16 0.81 -0.061
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 244.60 33.54
P/E High - Last 5 Yrs. 9.46 290.57 47.76
P/E Low - Last 5 Yrs. 9.46 100.09 25.07
Beta -0.59 0.74 0.79
Price to Sales (TTM) 17.57 253.05 8.28
Price to Book (MRQ) 27.91 23.78 4.21
Price to Tangible Book (MRQ) 27.14 30.85 6.00
Price to Cash Flow (TTM) -- 144.30 22.70
% Owned Institutions 5.77 12.00 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.74
Dividend Yield - 5 Year Avg -- 0.20 1.43
Dividend 5 Year Growth Rate -- 2.17 -6.29
Payout Ratio(TTM) -- 41.14 41.21

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -60.42 26.93 5.43
Sales (TTM) vs TTM 1 Yr. Ago -51.20 139.59 12.81
Sales - 5 Yr. Growth Rate -11.41 31.30 7.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 28.31 -77.66 40.97
EPS (TTM) vs TTM 1 Yr. Ago -147.82 -- --
EPS - 5 Yr. Growth Rate -- 48.96 8.04
Capital Spending - 5 Yr. Growth Rate -52.30 36.68 7.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.55
Current Ratio (MRQ) 3.85 6.40 3.62
LT Debt to Equity (MRQ) 0.00 22.45 13.20
Total Debt to Equity (MRQ) 0.00 26.80 17.68
Interest Coverage (TTM) -- -139.93 36.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.67 55.10
Gross Margin - 5 Yr. Avg. -- 55.13 52.98
EBITD Margin (TTM) -362.10 -- --
EBITD - 5 Yr. Avg -289.41 -167.31 15.70
Operating Margin (TTM) -363.37 -893.25 -0.37
Operating Margin - 5 Yr. Avg. -226.07 -180.81 10.89
Pre-Tax Margin (TTM) -587.21 -786.04 1.60
Pre-Tax Margin - 5 Yr. Avg. -223.78 -184.17 11.06
Net Profit Margin (TTM) -587.21 -779.78 -1.69
Net Profit Margin - 5 Yr. Avg. -223.78 -182.64 7.42
Effective Tax Rate (TTM) -- 15.40 29.75
Effective Tax Rate - 5 Yr. Avg. -- 19.25 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,874,759 727,953,282
Net Income/Employee (TTM) -- -152,114 84,747,764
Receivable Turnover (TTM) 3.60 18.30 6.05
Inventory Turnover (TTM) -- 2.83 3.67
Asset Turnover (TTM) 0.14 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -84.50 -3.57 10.32
Return on Assets - 5 Yr. Avg. -55.46 -0.71 10.99
Return on Investment (TTM) -270.00 -5.33 13.09
Return on Investment - 5 Yr. Avg. -237.00 2.10 14.27
Return on Equity (TTM) -266.16 -6.88 15.10
Return on Equity - 5 Yr. Avg. -385.25 -3.17 15.63
  1 Year 3 Year 5 Year
Sales % -44.62 -19.26 -11.41
EPS (TTM) % -258.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.77%
# of Holders: 23
Total Shares Held: 652,259
3 Mo. Net Change: 47,316
# New Positions: 3
# Closed Positions: 5
# Increased Positions: 6
# Reduced Positions: 6
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.